IDEXX Laboratories Revenue 2012-2025 | IDXX
IDEXX Laboratories annual/quarterly revenue history and growth rate from 2012 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- IDEXX Laboratories revenue for the quarter ending September 30, 2025 was $1.105B, a 13.29% increase year-over-year.
- IDEXX Laboratories revenue for the twelve months ending September 30, 2025 was $4.167B, a 8.39% increase year-over-year.
- IDEXX Laboratories annual revenue for 2024 was $3.898B, a 6.46% increase from 2023.
- IDEXX Laboratories annual revenue for 2023 was $3.661B, a 8.72% increase from 2022.
- IDEXX Laboratories annual revenue for 2022 was $3.367B, a 4.73% increase from 2021.
|
IDEXX Laboratories Annual Revenue (Millions of US $) |
|
|---|---|
| 2024 | $3,898 |
| 2023 | $3,661 |
| 2022 | $3,367 |
| 2021 | $3,215 |
| 2020 | $2,707 |
| 2019 | $2,407 |
| 2018 | $2,213 |
| 2017 | $1,969 |
| 2016 | $1,775 |
| 2015 | $1,602 |
| 2014 | $1,486 |
| 2013 | $1,377 |
| 2012 | $1,293 |
| 2011 | $1,219 |
|
IDEXX Laboratories Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2025-09-30 | $1,105 |
| 2025-06-30 | $1,109 |
| 2025-03-31 | $998 |
| 2024-12-31 | $954 |
| 2024-09-30 | $976 |
| 2024-06-30 | $1,004 |
| 2024-03-31 | $964 |
| 2023-12-31 | $902 |
| 2023-09-30 | $916 |
| 2023-06-30 | $944 |
| 2023-03-31 | $900 |
| 2022-12-31 | $829 |
| 2022-09-30 | $842 |
| 2022-06-30 | $861 |
| 2022-03-31 | $837 |
| 2021-12-31 | $801 |
| 2021-09-30 | $810 |
| 2021-06-30 | $826 |
| 2021-03-31 | $778 |
| 2020-12-31 | $721 |
| 2020-09-30 | $722 |
| 2020-06-30 | $638 |
| 2020-03-31 | $626 |
| 2019-12-31 | $605 |
| 2019-09-30 | $605 |
| 2019-06-30 | $620 |
| 2019-03-31 | $576 |
| 2018-12-31 | $549 |
| 2018-09-30 | $545 |
| 2018-06-30 | $581 |
| 2018-03-31 | $538 |
| 2017-12-31 | $506 |
| 2017-09-30 | $492 |
| 2017-06-30 | $509 |
| 2017-03-31 | $462 |
| 2016-12-31 | $443 |
| 2016-09-30 | $448 |
| 2016-06-30 | $467 |
| 2016-03-31 | $418 |
| 2015-12-31 | $400 |
| 2015-09-30 | $406 |
| 2015-06-30 | $413 |
| 2015-03-31 | $382 |
| 2014-12-31 | $352 |
| 2014-09-30 | $384 |
| 2014-06-30 | $390 |
| 2014-03-31 | $360 |
| 2013-12-31 | $354 |
| 2013-09-30 | $338 |
| 2013-06-30 | $353 |
| 2013-03-31 | $332 |
| 2012-12-31 | $320 |
| 2012-09-30 | $315 |
| 2012-06-30 | $336 |
| 2012-03-31 | $323 |
| 2011-12-31 | $307 |
| 2011-09-30 | $301 |
| 2011-06-30 | $318 |
| 2011-03-31 | $293 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $57.123B | $3.898B |
| IDEXX Laboratories, Inc. is a developer, manufacturer and distributor of products and services primarily for the companion animal veterinary, livestock and poultry, water testing and dairy markets. The company also sells a series of portable electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $232.458B | 27.62 |
| Intuitive Surgical (ISRG) | United States | $191.785B | 75.04 |
| Edwards Lifesciences (EW) | United States | $48.948B | 32.82 |
| IQVIA Holdings (IQV) | United States | $40.477B | 22.57 |
| Alcon (ALC) | Switzerland | $39.075B | 26.33 |
| Mettler-Toledo (MTD) | United States | $29.838B | 34.91 |
| DexCom (DXCM) | United States | $27.122B | 37.39 |
| STERIS (STE) | Ireland | $26.367B | 27.22 |
| Waters (WAT) | United States | $23.067B | 30.50 |
| Coloplast (CLPBY) | Denmark | $20.080B | 34.27 |
| Hologic (HOLX) | United States | $16.713B | 17.56 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.207B | 0.00 |
| Penumbra (PEN) | United States | $13.737B | 96.63 |
| Globus Medical (GMED) | United States | $12.510B | 26.26 |
| Masimo (MASI) | United States | $7.630B | 24.45 |
| Glaukos (GKOS) | United States | $6.906B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $6.194B | 19.68 |
| TransMedics (TMDX) | United States | $4.900B | 58.04 |
| Teleflex (TFX) | United States | $4.552B | 7.25 |
| LivaNova (LIVN) | United Kingdom | $3.392B | 18.32 |
| Veracyte (VCYT) | United States | $3.286B | 37.45 |
| Integer Holdings (ITGR) | United States | $3.006B | 14.11 |
| Alphatec Holdings (ATEC) | United States | $2.635B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.510B | 23.48 |
| Artivion (AORT) | United States | $2.056B | 94.33 |
| Nihon Kohden (NHNKY) | Japan | $2.038B | 17.79 |
| UFP Technologies (UFPT) | United States | $2.009B | 26.53 |
| PROCEPT BioRobotics (PRCT) | United States | $1.698B | 0.00 |
| AxoGen (AXGN) | United States | $1.431B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.367B | 0.00 |
| IRadimed (IRMD) | United States | $1.298B | 61.82 |
| OPKO Health (OPK) | United States | $0.983B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.967B | 5.24 |
| Pulse Biosciences (PLSE) | United States | $0.966B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.814B | 0.00 |
| SiBone (SIBN) | United States | $0.738B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.680B | 39.56 |
| Pacific Biosciences Of California (PACB) | United States | $0.667B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.604B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.573B | 11.43 |
| NeuroPace (NPCE) | United States | $0.564B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.556B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.490B | 13.52 |
| OrthoPediatrics (KIDS) | United States | $0.460B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.431B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.416B | 0.00 |
| RxSight (RXST) | United States | $0.403B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.366B | 61.00 |
| Sight Sciences (SGHT) | United States | $0.342B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Spectral Diagnostics (EDTXF) | Canada | $0.293B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.211B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.206B | 0.00 |
| 908 Devices (MASS) | United States | $0.198B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.185B | 0.00 |
| Inogen (INGN) | United States | $0.170B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.168B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.167B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.152B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.144B | 0.00 |
| LENSAR (LNSR) | United States | $0.142B | 0.00 |
| CVRx (CVRX) | United States | $0.137B | 0.00 |
| Solana (HSDT) | United States | $0.136B | 0.00 |
| Neuronetics (STIM) | United States | $0.130B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.129B | 0.00 |
| Hyperfine (HYPR) | United States | $0.117B | 0.00 |
| Accuray (ARAY) | United States | $0.095B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.087B | 0.00 |
| DarioHealth (DRIO) | United States | $0.084B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.079B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.069B | 0.00 |
| InspireMD (NSPR) | United States | $0.067B | 0.00 |
| Positron (POSC) | United States | $0.054B | 0.00 |
| Spectral AI (MDAI) | United States | $0.048B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.031B | 0.00 | |
| Ekso Bionics Holdings (EKSO) | United States | $0.023B | 0.00 |
| Envoy Medical (COCH) | United States | $0.020B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.017B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.014B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.014B | 0.00 |
| NexGel (NXGL) | United States | $0.013B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| Venus Concept (VERO) | Canada | $0.011B | 0.00 |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| PAVmed (PAVM) | United States | $0.007B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| ENvue Medical (FEED) | United States | $0.001B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 10.55 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |